Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3318894
Max Phase: Preclinical
Molecular Formula: C16H23NO
Molecular Weight: 245.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3318894
Max Phase: Preclinical
Molecular Formula: C16H23NO
Molecular Weight: 245.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN1CC[C@@H]2CC[C@H](OCc3ccccc3)C[C@@H]21
Standard InChI: InChI=1S/C16H23NO/c1-17-10-9-14-7-8-15(11-16(14)17)18-12-13-5-3-2-4-6-13/h2-6,14-16H,7-12H2,1H3/t14-,15-,16-/m0/s1
Standard InChI Key: XJBIRLCXDMVDOD-JYJNAYRXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 245.37 | Molecular Weight (Monoisotopic): 245.1780 | AlogP: 3.08 | #Rotatable Bonds: 3 |
Polar Surface Area: 12.47 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.14 | CX LogP: 2.79 | CX LogD: 0.12 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.81 | Np Likeness Score: 0.44 |
1. Jepsen TH, Jensen AA, Lund MH, Glibstrup E, Kristensen JL.. (2014) Synthesis and Pharmacological Evaluation of DHβE Analogues as Neuronal Nicotinic Acetylcholine Receptor Antagonists., 5 (7): [PMID:25050162] [10.1021/ml500094c] |
Source(1):